Analysis of hydroxychloroquine prescriptions for COVID‐19 in Japan

Analysis of hydroxychloroquine prescriptions for COVID‐19 in Japan

Bibliographic Details
Main Authors:	Takashi Watari, Yasuharu Tokuda, Hiromizu Takahashi, Kiyosu Taniguchi, Kenji Shibuya
Format:	Article
Language:	English
Published:	Wiley 2023-05-01
Series:	Journal of General and Family Medicine
Online Access:	https://doi.org/10.1002/jgf2.592

Similar Items

Prevalence and characteristics of antibiotic prescription for acute COVID-19 patients in Japan
by: Seiji Hamada, et al.
Published: (2022-12-01)

Association between hospital internal medicine physician workforce and patient admissions during the COVID-19 pandemic in Japan
by: Seiji Hamada, et al.
Published: (2023-01-01)

Evidence‐based prescription of corticosteroids for COVID‐19 patients: A comparison between general medicine and other specialty in Japan
by: Kota Sakaguchi, et al.
Published: (2023-03-01)

Comparing clinical outcomes of ARB and ACEi in patients hospitalized for acute COVID-19
by: Seiji Hamada, et al.
Published: (2023-07-01)

Intravenous methylprednisolone pulse therapy and the risk of in-hospital mortality among acute COVID-19 patients: Nationwide clinical cohort study
by: Takuhiro Moromizato, et al.
Published: (2023-02-01)

Estimating COVID‐19 herd immunity in Japan at the beginning of the seventh wave: Transitioning from a pandemic to an endemic
by: Toshikazu Kuniya, et al.
Published: (2022-09-01)

Safety culture survey among medical residents in Japan: a nationwide cross-sectional study
by: Yasuharu Tokuda, et al.
Published: (2023-11-01)

Educational strategies for general medicine education in accordance with the model core curriculum for medical education in Japan
by: Kiyoshi Shikino, et al.
Published: (2023-07-01)

Survey of potentially inappropriate prescriptions for common cold symptoms in Japan: A cross-sectional study.
by: Yasuhisa Nakano, et al.
Published: (2022-01-01)

Chloroquine, hydroxychloroquine and COVID-19
by: Erickson, T. B., et al.
Published: (2020)

Real-world prescription of anti-COVID-19 drugs in hospitalized patients with COVID-19 in Japan
by: Haruka Shida, et al.
Published: (2024-01-01)

Association between mentorship and mental health among junior residents: A nationwide cross‐sectional study in Japan
by: Kohta Katayama, et al.
Published: (2024-01-01)

Characteristics and trends of medical malpractice claims in Japan between 2006 and 2021
by: Kaori Taniguchi, et al.
Published: (2023-01-01)

Hydroxychloroquine, TTP, COVID-19, and SLE
by: Pathum Sookaromdee, et al.
Published: (2021-02-01)

The use of Hydroxychloroquine in the Treatment of COVID-19
by: Kamer TECEN-YÜCEL, et al.
Published: (2020-09-01)

Educational strategies related to information science and technology for medical students: General medicine physicians' perspective
by: Kiyoshi Shikino, et al.
Published: (2024-01-01)

Outside any therapeutic trial prescription of hydroxychloroquine for hospitalized patients with covid-19 during the first wave of the pandemic: A national inquiry of prescription patterns among French hospitalists.
by: Antoine Bosquet, et al.
Published: (2022-01-01)

Hydroxychloroquine for COVID-19: Balancing contrasting claims
by: Horby, PW, et al.
Published: (2020)

Hydroxychloroquine in hospitalized patients with Covid-19. Reply
by: Horby, P, et al.
Published: (2021)

Effect of hydroxychloroquine in hospitalized patients with COVID-19
by: Horby, P, et al.
Published: (2020)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
by: Tzu-Chuan Ho, et al.
Published: (2021-02-01)

The use of Azithromycin and Hydroxychloroquine in the Treatment of Covid-19
by: Ma Yue, et al.
Published: (2023-01-01)

Letter to the editor: The effect of hydroxychloroquine on COVID-19
by: Canan Demir, et al.
Published: (2022-01-01)

Medical resident’s pursuing specialty and differences in clinical proficiency among medical residents in Japan: a nationwide cross-sectional study
by: Takashi Watari, et al.
Published: (2023-06-01)

A critical analysis and review of Lancet COVID-19 hydroxychloroquine study
by: Mondher Toumi, et al.
Published: (2020-01-01)

An independent appraisal and re-analysis of hydroxychloroquine treatment trial for COVID-19
by: Katheron Intson, et al.
Published: (2020-04-01)

Rheumotologitsts’ view on the use of hydroxychloroquine to treat COVID-19
by: Xiaoxuan Sun, et al.
Published: (2020-01-01)

Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
by: Filippo Albani, et al.
Published: (2020-08-01)

Proarrhythmic effects of chloroquine and hydroxychloroquine in the context of Covid-19
by: Carlos Enrique Salgado-Fuentes
Published: (2021-05-01)

The Japanese Guide affected the prescription of steroids for COVID-19 inpatients during the COVID-19 epidemic in Japan
by: Takuya Higuchi, et al.
Published: (2023-06-01)

Treatment interruption in hypertensive patients during the COVID‐19 pandemic: An interrupted time series analysis using prescription data in Okayama, Japan
by: Naoko Nakamura, et al.
Published: (2024-03-01)

Empathy competence and future specialty among medical residents in Japan: a nationwide cross-sectional study
by: Takashi Watari, et al.
Published: (2023-08-01)

Distribution of internal medicine rotations among resident physicians in Japan: a nationwide, multicenter, cross-sectional study
by: Kiyoshi Shikino, et al.
Published: (2024-03-01)

Effect of hydroxychloroquine in hospitalized patients with COVID-19 - preliminary report
by: Linsell, L, et al.
Published: (2020)

Biologic Functions of Hydroxychloroquine in Disease: From COVID-19 to Cancer
by: Britney Niemann, et al.
Published: (2022-11-01)

Cardiovascular Safety of Hydroxychloroquine–Azithromycin in 424 COVID-19 Patients
by: Matthieu Million, et al.
Published: (2023-04-01)

Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19
by: Waiting Tai, et al.
Published: (2021-08-01)

Hydroxychloroquine and chloroquine for COVID-19 infection. Rapid systematic review
by: Rafael Leite Pacheco, et al.
Published: (2020-03-01)

Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study.
by: Andrew Ip, et al.
Published: (2020-01-01)

Involuntary Movements Following Administration of Hydroxychloroquine for COVID-19 Pneumonia
by: Emmaline Zantua Fernando, et al.
Published: (2021-01-01)